On our investor pages you can read about Nightingale as an investment, our latest releases and reports as well as follow Nightingale's share price development.
Nightingale is a Finnish health technology company that aims to promote preventative health and help people stay healthy. Our blood analysis technology measures a large variety of biomarkers from a single blood sample and identifies personal risks for disease using unique health data assets. We provide people with comprehensive insights on health, help them make better decisions regarding their health and connect them with healthcare experts that offer preventative services for maintaining health. We strive to help millions of people prevent common lifestyle diseases in the future and, at the same time, to reduce the immense expenses of healthcare.
ir@nightingalehealth.com
Nightingale Health Plc's Annual General Meeting 2021 was held on October 28. For further information please visit Annual General Meeting 2021.
18/11/2021 Nightingale's corporate health service piloted at Mitsui headquarters in Tokyo
15/11/2021 Nightingale launches Nightingale Home and Nightingale Pro service models
8/11/2021 Nightingale Health Plc – Managers' transactions – Timo Soininen
2/11/2021 Tuukka Paavola appointed as Chief Financial Officer of Nightingale Health Plc
29/10/2021 Conversion of Nightingale Health Plc’s Series A shares and EMP shares to Series B shares
28/10/2021 Resolutions of Nightingale Health Plc’s Annual General Meeting and Board of Directors
28/10/2021 Recording of event: An hour with Nightingale
18/10/2021 Invitation to event: An hour with Nightingale
13/10/2021 Nightingale and Terveystalo launch a new well-being membership
7/10/2021 Nightingale receives CE marking for its at-home blood collection kit
1/10/2021 Notice to the Annual General Meeting of Nightingale Health Plc
1/10/2021 Nightingale's Annual Report for financial year 2020–2021 published